Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Resistance training does not protect against increases in plasma cytokine levels among germ cell cancer patients during and after chemotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Muscle-liver substrate fluxes in exercising humans and potential effects on hepatic metabolism

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Obesity is associated with earlier pubertal onset in boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular and metabolic health effects of team handball training in overweight women: Impact of prior experience

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Psychological stress in long-term testicular cancer survivors: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

CONTEXT: Testicular germ cell cancer (GCC) patients treated with cisplatin-etoposide-bleomycin chemotherapy (BEP) have excellent prognosis but have an increased risk of late-occurring morbidities, which may be associated with changes in the inflammatory profile.

OBJECTIVE: The objective of the study was to explore plasma cytokine concentrations in GCC patients randomized to resistance training or usual care during BEP, in comparison with healthy controls.

DESIGN/SETTING: This was a randomized controlled trial in GCC patients enrolled from an oncology clinic, including a healthy reference group for comparison purposes.

OUTCOME MEASURES: Plasma granulocyte macrophage colony-stimulating factor, interferon-γ, IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12, and TNF-α were measured in fasting blood samples from GCC patients randomized to resistance training (INT; n = 15) or usual care (CON; n = 15) and healthy age-matched controls (REF; n = 19). Clinical toxicity assessments and patient-reported end points were also recorded.

RESULTS: CON and INT were balanced at baseline. Compared with REF, CON had higher concentrations of IL-10, IL-6, and interferon-γ, and INT had higher concentrations of IL-6, IL-8 and TNF-α (all P < .05). At the end of therapy, concentrations of IL-6, IL-8, and IL-10 increased in both GCC groups (all P < .01). Three months after therapy, all cytokine concentrations were comparable with the pretreatment levels in both GCC-groups but remained elevated compared with REF (P < .05). Changes in TNF-α correlated with pulmonary toxicity (P < .01). At the end of therapy, IL-6 concentrations correlated with quality of life (P < .05) and fatigue (P < .01).

CONCLUSION: GCC patients treated with BEP display consistently elevated levels of systemic inflammatory markers compared with healthy controls. Resistance training during therapy has no impact on plasma cytokine concentrations.

Original languageEnglish
JournalThe Journal of clinical endocrinology and metabolism
Volume99
Issue number8
Pages (from-to)2967-76
Number of pages10
ISSN0021-972X
DOIs
Publication statusPublished - Aug 2014

    Research areas

  • Adult, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Cytokines, Humans, Interferon-gamma, Interleukin-10, Interleukin-6, Interleukin-8, Male, Neoplasms, Germ Cell and Embryonal, Resistance Training, Testicular Neoplasms, Tumor Necrosis Factor-alpha, Young Adult

ID: 45068807